![Madhavan Balachandran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Madhavan Balachandran
Direktor/Vorstandsmitglied bei
UNIQURE N.V.
Vermögen: 4 Mio $ am 30.09.2026
Profil
Zurzeit ist Madhavan Balachandran Chief Operating Officer bei Brentwood Press & Publishing Co. und Chief Operating Officer bei Nutcracker Therapeutics, Inc. Herr Balachandran ist außerdem im Vorstand von 5 weiteren Unternehmen. In der Vergangenheit hatte Herr Balachandran die Position des Chief Executive Officer & Director bei ADRx, Inc. inne, die des Executive Vice President bei Amgen, Inc. die des Vice President-Engineering bei Glaxo Wellcome, Inc. die des Principal beim Battelle Memorial Institute und die des Vice President der Puerto Rico USA Citizenship Foundation. Er erwarb einen MBA an der East Carolina University, einen Undergraduate-Abschluss am Indian Institute of Technology Bombay und einen Graduate-Abschluss an der State University of New York in Buffalo.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 69.458 ( 0,03 % ) | 1 Mio $ | 30.09.2026 | |
STEVANATO GROUP SPA 0,13 % | 31.12.2025 | 65.976 ( 0,13 % ) | 1 Mio $ | 30.09.2026 |
UNIQURE N.V. 0,06 % | 17.06.2026 | 43.254 ( 0,06 % ) | 1 Mio $ | 30.09.2026 |
| 30.06.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
Aktive Positionen von Madhavan Balachandran
| Unternehmen | Position | Beginn |
|---|---|---|
| UNIQURE N.V. | Direktor/Vorstandsmitglied | 14.09.2017 |
| STEVANATO GROUP S.P.A. | Direktor/Vorstandsmitglied | 01.09.2018 |
| REPLIMUNE GROUP, INC. | Direktor/Vorstandsmitglied | 05.09.2024 |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Develops medicine for treatment of neurodegenerative diseases and neurotrauma | Direktor/Vorstandsmitglied | 01.06.2018 |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. BiotechnologyHealth Technology Provides end-to-end RNA therapeutics research and development services | Corporate Officer/Principal | 23.09.2020 |
Brentwood Press & Publishing Co.
 Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Publishes newspapers | Geschäftsführer | 23.09.2020 |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Madhavan Balachandran
| Unternehmen | Position | Ende |
|---|---|---|
| CATALENT, INC. | Direktor/Vorstandsmitglied | 25.01.2024 |
ADRx, Inc.
 ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Vorstandsvorsitzender | 01.10.2020 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Madhavan Balachandran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization for science and technology research & development | Commercial Services |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Publishes newspapers | Consumer Services |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Puerto Rico USA Citizenship Foundation | |
Stevanato Group SpA
 Stevanato Group SpA Medical SpecialtiesHealth Technology Designs, manufacturers and supplies glass bottles and glass tube containers | Health Technology |
Indian Institute of Technology Bombay
 Indian Institute of Technology Bombay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Develops medicine for treatment of neurodegenerative diseases and neurotrauma | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. BiotechnologyHealth Technology Provides end-to-end RNA therapeutics research and development services | Health Technology |
ADRx, Inc.
ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Commercial Services |
